Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐<scp>BCMA CAR</scp> T‐cell‐based therapy

Yuekun Qi(Xuzhou Medical College), Jiang Cao(Xuzhou Medical College), Ying Wang(Xuzhou Medical College), Tingting Qiu(Huazhong University of Science and Technology), Ming Shi(Southwest Jiaotong University), Feng Zhu(Xuzhou Medical College), Wei Sang(Xuzhou Medical College), Bin Pan(Zhejiang Chinese Medical University), Xiaoming Fei(Jiangsu University), Junnian Zheng(Xuzhou Medical College), Wei Chen(Xuzhou Medical College), Kunming Qi(Xuzhou Medical College), Yuqing Miao(Nantong University), Jianlin Qiao(Xuzhou Medical College), Gang Wang(Wuhan University), Zhiling Yan(Xuzhou Medical College), Kailin Xu(Xuzhou Medical College), Weiying Gu(The First People's Hospital of Changzhou), Hongming Huang(Nantong University), Depeng Li(Xuzhou Medical College), Zhenyu Li(Second Hospital of Tianjin Medical University), Hai Cheng(Xuzhou Medical College), Hujun Li(Xuzhou Medical College)
American Journal of Hematology
August 28, 2024
Cited by 21


Related Papers